Collectively, these results suggest that the cellular productions of n-3 PUFAs and lowered n−6/n−3 ratio effectively alleviates hyperlipidemia, which is closely correlated with CRC associated with APC mutation, possibly via suppression of mTORC1 activity in adipogenesis. The gene discussed is APC; the disease is hyperlipidemia.